BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31111144)

  • 1. Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department.
    Etaher A; Gibbs OJ; Saad YM; Frost S; Nguyen TL; Ferguson I; Juergens CP; Chew D; French JK
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):41-48. PubMed ID: 31111144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality at 5 Years Among Very Elderly Patients Undergoing High Sensitivity Troponin T Testing for Suspected Acute Coronary Syndromes.
    Etaher A; Nguyen TL; Saad YM; Frost S; Ferguson I; Juergens CP; Chew D; French JK
    Heart Lung Circ; 2020 Nov; 29(11):1696-1703. PubMed ID: 32439246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implications of High-Sensitivity Troponin T Levels Among Patients Attending Emergency Departments and Evaluated for an Acute Coronary Syndrome.
    Etaher A; Chew DP; Frost S; Saad YM; Ferguson I; Nguyen TL; Juergens CP; French JK
    Am J Med; 2021 Aug; 134(8):1019-1028.e1. PubMed ID: 33812862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcomes with 5-year mortality of patients with mildly elevated high-sensitivity troponin T levels not meeting criteria for myocardial infarction.
    Alazrag W; Idris H; Saad YM; Etaher A; Ren S; Ferguson I; Juergens C; Chew DP; Otton J; Middleton PM; French JK
    Emerg Med Australas; 2024 Feb; 36(1):62-70. PubMed ID: 37705175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.
    Etaher A; Chew D; Redfern J; Briffa T; Ellis C; Hammett C; Lefkovits J; Elliott J; Cullen L; Brieger D; French JK
    Heart Lung Circ; 2017 Oct; 26(10):1051-1058. PubMed ID: 28139353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    Chuang AM; Nguyen MT; Khan E; Jones D; Horsfall M; Lehman S; Smilowitz NR; Lambrakis K; Than M; Vaile J; Sinhal A; French JK; Chew DP
    PLoS One; 2021; 16(3):e0248289. PubMed ID: 33711079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy.
    Celik S; Giannitsis E; Wollert KC; Schwöbel K; Lossnitzer D; Hilbel T; Lehrke S; Zdunek D; Hess A; Januzzi JL; Katus HA
    Clin Res Cardiol; 2011 Dec; 100(12):1077-85. PubMed ID: 21792561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial Infarction.
    Wassie M; Lee MS; Sun BC; Wu YL; Baecker AS; Redberg RF; Ferencik M; Shen E; Musigdilok V; Sharp AL
    JAMA Netw Open; 2021 Feb; 4(2):e2037930. PubMed ID: 33620444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X; Tamez H; Lai C; Ho K; Cutlip D
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prehospital Modified HEART Score Predictive of 30-Day Adverse Cardiac Events.
    Stopyra JP; Harper WS; Higgins TJ; Prokesova JV; Winslow JE; Nelson RD; Alson RL; Davis CA; Russell GB; Miller CD; Mahler SA
    Prehosp Disaster Med; 2018 Feb; 33(1):58-62. PubMed ID: 29316995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.
    Wang TK; Stewart RA; Ramanathan T; Kang N; Gamble G; White HD
    Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):323-33. PubMed ID: 24338291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).
    Connolly M; Shand J; Kinnin M; Menown I; Kurth MJ; Lamont J; Mc Eneaney D
    QJM; 2018 Jan; 111(1):33-38. PubMed ID: 29040663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
    Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
    Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high-sensitivity cardiac troponin I assays on patients presenting to an emergency department with suspected acute coronary syndrome.
    Yip TP; Pascoe HM; Lane SE
    Med J Aust; 2014 Aug; 201(3):158-61. PubMed ID: 25128951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Cediel G; Gonzalez-Del-Hoyo M; Carrasquer A; Sanchez R; Boqué C; Bardají A
    Heart; 2017 Apr; 103(8):616-622. PubMed ID: 27742797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of routine point-of-care cardiac troponin T measurement for prehospital diagnosis and risk-stratification in patients with suspected acute myocardial infarction.
    Rasmussen MB; Stengaard C; Sørensen JT; Riddervold IS; Hansen TM; Giebner M; Rasmussen CH; Bøtker HE; Terkelsen CJ
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):299-308. PubMed ID: 29199427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome.
    Vafaie M; Slagman A; Möckel M; Hamm C; Huber K; Müller C; Vollert JO; Blankenberg S; Katus HA; Liebetrau C; Giannitsis E; Searle J
    Am J Med; 2016 Mar; 129(3):274-82.e2. PubMed ID: 26524709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a high-sensitivity troponin T assay in the assessment and disposition of patients attending a tertiary Australian emergency department: a cross-sectional pilot study.
    Saad YM; McEwan J; Shugman IM; Mussap C; Juergens CP; Ferguson I; French JK
    Emerg Med Australas; 2015 Oct; 27(5):405-11. PubMed ID: 26114735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.